Forte Biosciences (FBRX) Misses Q3 EPS by 433c

Forte Biosciences (NASDAQ: FBRX) reported Q3 EPS of ($4.54), $4.33 worse than the analyst estimate of ($0.21).

For earnings history and earnings-related data on Forte Biosciences (FBRX) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Lockheed, RTX, Boeing, L3Harris expected to meet with Trump - WSJ
• Unifor starts contract talks with Ford for 5,150 workers